Results 121 to 130 of about 3,030,606 (198)

Laboratory surveillance for wild poliovirus and vaccine-derived poliovirus, 2000-2001.

MMWR. Morbidity and mortality weekly report, 2002
After the 1988 World Health Assembly resolution to eradicate poliomyelitis, the Global Laboratory Network for Poliomyelitis Eradication (the laboratory network) was established by the World Health Organization (WHO). The laboratory network is one component of the international surveillance system for detecting polio through notification of cases of ...
openaire   +1 more source

Detection of Polioviruses Type 2 among Migrant Children Arriving to the Russian Federation from a Country with a Registered Poliomyelitis Outbreak

Vaccines
The widespread use of the oral poliovaccine from Sabin strains (tOPV) radically reduced poliomyelitis incidence worldwide. However, OPV became a source of neurovirulent vaccine-derived polioviruses (VDPVs).
Olga E. Ivanova, Tatiana P. Eremeeva, Olga Y. Baykova, Alexandr Y. Krasota, Elizaveta V. Yakovchuk, Elena Y. Shustova, Lyudmila P. Malyshkina, Aida N.-I. Mustafina, Yulia M. Mikhailova, Alina V. Chirova, Evgeniya A. Cherepanova, Nadezhda S. Morozova, Anna S. Gladkikh, Anna S. Dolgova, Vladimir G. Dedkov, Areg A. Totolian, Liubov I. Kozlovskaya   +16 more
doaj   +1 more source

Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man

, 2004
BACKGROUND: Individuals who chronically excrete neurovirulent poliovirus of vaccine-origin are of considerable concern to the Global Polio Eradication programme.
Martin, J, Kumararatne, Dinakantha, Huissoon, Aarnoud, Pillay, Deenan, Thomson, RA, MacLennan, Calman, O'Leary, P, Dunn, G, Osman, H, Wood, P   +9 more
core   +1 more source

Advances and challenges in poliomyelitis vaccines: a comprehensive review of development, production, and global deployment

Frontiers in Public Health
Poliomyelitis has been a significant global health challenge for centuries. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, remarkable progress has been achieved, with wild poliovirus (WPV) cases reduced by over 99%.
Jia Liang, Qi Zhang, Yanan Li, Lili Wang
doaj   +1 more source

Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs)

, 2013
The live, attenuated oral poliovirus vaccine (OPV) provides a powerful tool for controlling and stopping the transmission of wild polioviruses (WPVs), although the risks of vaccine-associated paralytic polio (VAPP) and circulating vaccine-derived ...

core   +1 more source

Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014–2017

, 2018
Pakistan began using inactivated poliovirus vaccine alongside oral vaccine in mass campaigns to accelerate eradication of wild-type poliovirus in 2014.
Abdirahman Sheikh Mahamud, Roland W. Sutter, Nicholas C. Grassly, Rana M. Safdar, Mufti Zubair Wadood   +4 more
core   +1 more source

Preparation and Inactivation of Purified Poliovirus: Comparison of Vaccines Derived from Mahoney and Parker Poliovirus

Experimental Biology and Medicine, 1957
J, CHARNEY, W P, FISHER, R A, MACHLOWITZ
openaire   +2 more sources

Preventing paralytic polio caused by vaccine-derived poliovirus type 2 [PDF]

The Lancet Infectious Diseases, 2020
Carlos, Franco-Paredes, Jose I, Santos-Preciado, Andres F, Henao-Martinez, Alfonso J, Rodriguez-Morales, Peter, Carrasco   +4 more
openaire   +2 more sources

Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2021-December 2022. [PDF]

MMWR Morb Mortal Wkly Rep, 2023
Bigouette JP, Henderson E, Traoré MA, Wassilak SGF, Jorba J, Mahoney F, Bolu O, Diop OM, Burns CC.   +8 more
europepmc   +1 more source

Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK children. [PDF]

Nat Commun, 2023
Singanayagam A, Klapsa D, Burton-Fanning S, Hand J, Wilton T, Stephens L, Mate R, Shillitoe B, Celma C, Slatter M, Flood T, Gopal R, Martin J, Zambon M.   +13 more
europepmc   +1 more source